Transcriptomics

Dataset Information

0

Simvastatin treated Lymphoblastoid Cell lines from Cholesterol and Pharmacogenomics (CAP) Trial


ABSTRACT: Statins reduce cardiovascular disease risk by lowering plasma low density lipoprotein (LDL)-cholesterol. To identify novel pathways that modulate statin response, we assessed the influence of simvastatin exposure on expression quantitative trait locus (eQTL) associations across the genome in 480 lymphoblastoid cell lines (LCLs). Cell lines were derived blood samples collected ant entry visit from participants in the Cholesterol and Pharmacogenomics (CAP) trial, who underwent a 6 week 40mg/day simvastatin trial. We identified 4590 cis-eQTLS that were independent of treatment status (FDR=1%) and six cis-eQTLS for which there was evidence of an interaction with treatment (FDR=20%). Genotypes and Phenotypes derived from these indivudals are available through dbGaP (Accession Number). eQTL results are available at: http://eqtl.uchicago.edu/cgi=bin/gbrowse/eqtl/

ORGANISM(S): Homo sapiens

PROVIDER: GSE36868 | GEO | 2012/07/01

SECONDARY ACCESSION(S): PRJNA157039

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-06-30 | E-GEOD-36868 | biostudies-arrayexpress
2016-06-10 | GSE83141 | GEO
2019-08-22 | GSE114225 | GEO
2016-06-10 | E-GEOD-83141 | biostudies-arrayexpress
2013-11-21 | E-MTAB-1501 | biostudies-arrayexpress
2018-09-24 | GSE116006 | GEO
2006-12-31 | GSE4883 | GEO
2014-06-05 | E-GEOD-58239 | biostudies-arrayexpress
2014-06-05 | GSE58239 | GEO
2018-04-28 | E-MTAB-6666 | biostudies-arrayexpress